CRISPR Therapeutics AG

Ownership Transactions Reported by 21 Insiders

Symbol
CRSP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Baarerstrasse 14, Zug, Switzerland

Insiders trading volume in the past year

CRISPR Therapeutics AG executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Simeon George Director $55M May 30, 2024
Rodger Novak President, Director $35.8M Jun 30, 2021
Samarth Kulkarni Chief Executive Officer, Director $14.7M -$12.8M -46.5% Dec 2, 2024
Tony W. Ho Executive VP, Head of R&D $3.27M Dec 3, 2021
James R. Kasinger General Counsel and Secretary $2.9M -$507K -14.9% Oct 16, 2024
Julianne Bruno Chief Operating Officer $776K -$189K -19.6% Oct 16, 2024
Raju Prasad Chief Financial Officer $471K -$256K -35.2% Oct 16, 2024
Brendan Smith Chief Financial Officer $317K Feb 18, 2023
Phuong Khanh Morrow Chief Medical Officer $276K Oct 13, 2023
Michael John Tomsicek Chief Financial Officer $118K Aug 6, 2021
Lawrence Klein Cbo & Coo Aug 16, 2022
Katherine A. High Director May 30, 2024
Christian Rommel Director May 30, 2024
Sandesh Mahatme Director May 30, 2024
Ali Behbahani Director May 30, 2024
Bradley J. Bolzon PhD Director Jun 9, 2022
John Greene Director May 30, 2024
Maria Fardis Director May 30, 2024
Naimish Patel Chief Medical Officer Oct 16, 2024
Harold Edward Fleming Director May 30, 2024
Douglas A. Treco Director May 30, 2024

Recent Insider Transactions by Companies or Individuals for CRISPR Therapeutics AG

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.